Neomorph is a biotech company targeting protein degradation to eliminate disease-linked and previously labeled 'undruggable' proteins. The team's expertise in protein degradation and molecular glues allows them to develop heterobifunctional molecules that can degrade proteins using a molecular glue mechanism. Neomorph is collaborating with the Center for Protein Degradation at the Dana Farber Cancer Institute, as well as Novo Nordisk to discover and develop drugs for cardiometabolic and rare diseases. They were founded in 2020 with headquarters located in San Diego, CA.

Neomorph

Associate Principal Scientist, Computational Chemistry

Director, Virology

Scientist I / II, Cell & Molecular Biology (Bench focused)

Biogen and Neomorph enter molecular glue degrader deal - Pharmaceutical Technology

We're #hiring a new Senior Scientist, Computational Chemistry in San Diego, California. Apply today or share this post with your network.

Celebrating Lisa Strong's remarkable contributions to our team. Keep up the great work!

Biogen, Neomorph to collaborate on clinical candidates for Alzheimer's (NASDAQ:BIIB) - Seeking Alpha

We're #hiring a new Corporate Controller in San Diego Metropolitan Area. Apply today or share this post with your network.

Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal - geneonline.com

 Neomorph Inks $1.46B Deal with Novo Nordisk 

 Novo Nordisk signs $1.46bn deal to develop molecular glue therapies 

 AbbVie and Neomorph seal glue degrader deal 

Novo Inks Potential $1.46B Deal to Tap Neomorph’s Molecular Glue Platform - BioSpace

 Novo Nordisk sticks down $1.46B in biobucks for molecular glues 

 Substituted 2-(2,6-dioxopiperidin-3-yl)-5-(1-piperidin-4-yl)isoindoline-1,3- … 

 AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B 

Alien: Covenant Photos Show Bloody Neomorph Carnage - MovieWeb


              Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
            

We're #hiring a new Assoc. Scientist, Analytical Chemistry in San Diego Metropolitan Area. Apply today or share this post with your network.

 Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for ... 

 Appointments and advancements for Jan. 15, 2025 

Alien: Covenant Photos Reveal Baby Neomorph, Ancient Temple & More - MovieWeb

New 'Alien: Covenant' Images Reveal The Creepy 'Neomorph' - SlashFilm

What is 'The Offspring' creature in the 'Alien: Romulus' finale? - Space

Neomorph vs Xenomorph fight scene was cut from Alien: Covenant - JoBlo.com

AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology - PR Newswire

Neomorph - Alien vs. Predator Galaxy

AbbVie partners with Neomorph in latest molecular glue deal - Endpoints News

Mixed results for Keytruda; AbbVie to work with Neomorph - BioPharma Dive

There Was Going to Be a Xenomorph vs Neomorph Fight in ‘Alien: Covenant’ - Bloody Disgusting

My Life as a Teenaged Neomorph: Experiencing ‘Alien Covenant: In Utero’ - The Knoxville Mercury

Click here for Webcast

Neomorph Pulls $109 Million - San Diego Business Journal

Neomorph, AbbVie strike $1.64 billion deal - statnews.com

We're #hiring a new Scientist II, Biomolecular Simulations - Comp Chemistry in San Diego Metropolitan Area. Apply today or share this post with your network.

Ridley Scott: Inspiration for Alien: Covenant's Neomorph - IGN

New ‘Alien: Covenant’ Photos Reveal the Neomorph in All Its Gruesome Glory - ScreenCrush

We're #hiring a new Senior / Executive Director, CMC in San Diego Metropolitan Area. Apply today or share this post with your network.

We're #hiring a new Director, DMPK in San Diego, California. Apply today or share this post with your network.

 AbbVie, Neomorph to develop molecular glue degraders 

Novo Nordisk doles out $1.4B for molecular glue degraders licensing pact - MM+M Online

https://neomorph.com/index.html#news

 Biogen, Neomorph announces multi-target research collaboration 

Novo Nordisk joins molecular glue club with Neomorph deal - pharmaphorum

Sideshow & CoolProps Life-Size Neomorph Head Replica Available for Pre-Order - AvP Galaxy


                    Philip Chamberlain Named as Chief Executive Officer of Neomorph
                

Alien: Covenant Concept Art Reveals Early Neomorph Design - Screen Rant

Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B - Fierce Biotech

Novo Nordisk sticks down $1.46B in biobucks for molecular glues with California biotech - Fierce Biotech

We're #hiring a new Director, Virology in San Diego Metropolitan Area. Apply today or share this post with your network.


                    Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs
                

 Neomorph, Abbvie to develop molecular glue degraders in $1.64B deal 

Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs - Business Wire

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases - StockTitan

Alien: 5 Reasons Why Neomorphs Are Deadlier Than Xenomorphs (& 5 Why They're Not) - Screen Rant

 Neomorph’s $1.6 Billion Collaboration with AbbVie 

 AbbVie partners with Neomorph in latest molecular glue deal 

Alien: Covenant Neomorph - Origin, Life Cycle & Xenomorph Differences - Screen Rant

Neomorph Vs. Xenomorph Fight Almost Happened in Alien: Covenant - MovieWeb

AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B - BioSpace

Creating the Creature Effects of Alien Covenant - AvP Galaxy

Novo Nordisk joins protein degradation race in $1.4B+ deal with Neomorph - FirstWord Pharma

Morphological evolution of the neomorph in Choristodera. Red branches... - ResearchGate

Fox Continues To Explore VR’s Selling Power With “Alien: Covenant In Utero” - Fast Company

Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometabolic and Rare Diseases - PR Newswire

AbbVie, Neomorph partner on protein degrader drugs - Investing.com

 Sticky, sticky, sticky: Neomorph tacks on another Big Pharma glue degrader deal with $1.6B AbbVie pact 

Celebrating Hidetomo I. for his dedication, passion, and outstanding contributions to our team!

Highlighting Fan Zheng for their remarkable achievements and hard work. 

Thank you for your commitment.

We're #hiring a new Sr Scientist, Biology in San Diego Metropolitan Area. Apply today or share this post with your network.

Neomorph Inks $1.46B Deal with Novo Nordisk - San Diego Business Journal

We're #hiring a new Scientist II, Biology in San Diego Metropolitan Area. Apply today or share this post with your network.

AbbVie and Neomorph enter molecular glue degrader partnership worth $1.64bn - PMLiVE

UBE2G1 governs the destruction of cereblon neomorphic substrates. Lu G, Weng S, Matyskiela M, Zheng X, Fang W, Wood S, Surka C, Mizukoshi R, Lu CC, Mendy D, Jang IS, Wang K, Marella M, Couto S, Cathers B, Carmichael J, Chamberlain P, Rolfe M. Elife. 2018 Sep 20;7:e40958. doi: 10.7554/eLife.40958. PMID: 30234487; PMCID: PMC6185104.
                    

‘Alien: Covenant’ VFX Team Hatches New Neomorph, Xenomorphs - Hollywood Reporter

Up to $1.45 billion on the line in Biogen and Neomorph deal - The Pharma Letter

AVERON notebook to discover actionable cancer vulnerabilities enabled by neomorph protein-protein interactions - ScienceDirect.com

www.neomorph.com

Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders - Inside Precision Medicine

‘Alien: Covenant’: How the VFX Team Engineered Those Terrifying Xenomorph and Neomorph Creatures - IndieWire

 AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology 

Protein degradation firm Neomorph racks up third pharma partner in $1.6B+ deal with AbbVie - FirstWord Pharma

Novo Nordisk and Neomorph enter molecular glue degrader partnership worth over $1.4bn - PMLiVE

Neomorph, Inc.

Colin Shulver Shares Neomorph & Xenomorph Concept Art from Alien: Covenant - AvP Galaxy

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases - Biogen | Investor Relations

Highlighting our Neomorph Operations team as they lead our lab's charge into the future!

'Alien: Covenant In Utero' Lets You Experience a Neomorph Birth in VR - Space.com

'Alien: Covenant In Utero' Lets You Experience a Neomorph Birth in VR - Live Science

AbbVie and Neomorph seal glue degrader deal - The Pharma Letter

 Neomorph Lands $1.45B Biogen Pact 

 Novo Nordisk joins molecular glue club with Neomorph deal 

Alien: Covenant - Get a Closer Look at the Neomorph - IGN Nordic

How Does Alien: Romulus Connect To Prometheus? - TheGamer

Last week, a few of our incredible female scientists participated in Women Who Inspire 2025, an event that celebrates the achievements, leadership, and impact of women in STEM. It was an inspiring day of connection, empowerment, and thought-provoking discussions.
 
At Neomorph, we’re proud to support and uplift the voices of women driving scientific breakthroughs. Thank you to Biocom California for hosting such an empowering event!

#WomenWhoInspire2025 #WomenInSTEM #LifeSciences #NeomorphInc #Biotech #Leadership #Biocom

Neomorph Appoints Philip Chamberlain As CEO - citybiz

Alien: Covenant Images Feature Neomorphs & Prometheus Connection - Screen Rant

Click here

Biogen signs molecular glue deal, raises yearly projections - Endpoints News

Biogen forges $1.4B+ deal with Neomorph around molecular glue degraders - FirstWord Pharma

 Neomorph Pulls $109 Million 

Neomorph

Business:

About: